Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report
<p>Abstract</p> <p>Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with pulmonary hemorrhage is rare in childhood. Standard treatment includes corticosteroids and cyclophosphamide (CYC), which is associated with a high level of toxicity. We report a white fe...
Main Authors: | Lehman Thomas JA, Baird Emily M, Worgall Stefan |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Pediatric Rheumatology Online Journal |
Online Access: | http://www.ped-rheum.com/content/9/1/33 |
Similar Items
-
Diversity of classic anti-neutrophil cytoplasmic antibody (cANCA) and perinuclear anti-neutrophil cytoplasmic antibody (pANCA) in vasculitides and autoimmune diseases
by: Fu Huey Ling, et al.
Published: (1999) -
Relapse in Anti-Neutrophil Cytoplasm Antibody (ANCA)–Associated Vasculitis
by: Alan D. Salama
Published: (2020-01-01) -
The immunogenetics of anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis
by: Rajp, Amit
Published: (2002) -
Pathogenesis and pathology of anti-neutrophil cytoplasmic antibody(ANCA)-associated vasculitis
by: Daisuke Tsukui, et al.
Published: (2021-01-01) -
Immunofluorescence (IF) pattern, autoantigens of anti-neutrophil cytoplasmic antibodies (ANCA) and their clinical associations
by: Masita Arip, et al.
Published: (2010)